The Vacuum engineering company Edwards is to set up a new service technology centre in Blanchardstown, in Dublin to support the semiconductor manufacturing industry here in Ireland.
Edwards supplies vacuum and abatement technology, along with the equipment and services, which are necessary to support the efficient and environmentally sustainable production of semiconductors.
The company said the centre in Blanchardstown will use advanced automation and data solutions to disassemble, clean, inspect, repair, replace and reassemble vacuum pumps and abatement equipment.
The new facility will include warehousing facilities, factory areas, meeting rooms, and a dedicated training centre to cater to the practical and theoretical training needs of both Edwards employees and those of its customers.
Troy Metcalf, President of Edwards Semiconductor Service, said the company’s new Dublin site will become a flagship facility in its global network of service technology centres.
Edwards’ investment here is being supported by IDA Ireland.
After a successful launch of its app in Ireland and parts of the UK, The Irish company ‘NearForm’ has launched similar technology in Delaware, USA.
Irish-based ‘NearForm’ is launching the Covid-19 Alert DE app in the US state of Delaware, in partnership with local authorities, to help track and trace the spread of Covid-19 .The app is very similar to the company’s current Covid Tracker Ireland app, which had great success at the beginning of July.
Both are built on the exposure notification API developed by Apple and Google, which identifies when one person comes in contact with another on the exact day of contact using Bluetooth ‘handshakes’ from their devices sending them a direct notification.While the Covid Alert DE app will be available to anyone over 18 who lives, works or attends college in Delaware, it will also allow for interoperability across the US in states that also have exposure notification apps based on the Bluetooth technology.
“The Covid Alert DE mobile app puts power in citizens’ hands to protect each other in the fight against Covid-19,” he added. “The open-source technology was built with privacy and data protection at its core.”
Since it was launched, the app has been downloaded by more than 1.7m people. NearForm’s contact-tracing tech is now being used in Ireland, Northern Ireland, Gibraltar and Scotland.
The €420 million data centre, the company’s first in Europe, is to be operational by 2022 and signals TikTok’s “long-term commitment” to Ireland, according to chief information security officer, Roland Cloutier.
Tik Tok Jobs
“My team is laser-focused on building our advanced security infrastructure, designing relevant programs, and engaging with the industry to develop our capabilities,” he said.
“This investment in Ireland, to the value of approximately €420million, will create hundreds of new “Tik Tok” jobs and play a key role in further strengthening the safeguarding and protection of TikTok user data.”
He added: “Ireland already plays a key role in our rapidly expanding European operations. Since establishing our EMEA Trust and Safety Hub in Dublin at the start of this year, we have rapidly expanded our team.”
TikTok hit the headlines recently after US President Donald Trump suggested it had links with the Chinese government and posed a security risk. Trump all but stopped short of signing an order that would ban the app in the US.
Tech giant Microsoft is now reported to be in talks to buy the app from Chinese owners ByteDance, with Trump claiming the US Government should get a slice of the pie if that deal goes through.
Since May, this year TikTok has already been downloaded over 2 billion times!
Ireland’s position as a global leader in the Medical Tech and Life Sciences sectors is underlined by the fact that 14 out of the world’s top 15 leading multinationals now have operations in Ireland.
Companies such as Boston Scientific, Medtronic, J&J/ DePuy, Stryker, Becton Dickinson, Baxter, Abbott and Cook continue to expand the sector, with many making significant ongoing investments.
“2018 saw a terrific combination of announcements from new names and existing companies,” explains Rachel Shelly, IDA’s Head of Medical Technologies Division, citing announcements by Edwards Lifesciences in the Mid West, the arrival of Quidel to Galway, expansions by Bausch and West Pharmaceuticals in Waterford, plus Avery Dennison in Longford.
She adds that innovation is also thriving, as seen by Becton Dickinson’s new global R&D centre in Limerick and Agilent Technologies Ireland opening of its purpose-built R&D extension to its Little Island facility in Co Cork.
“Companies like Abbott, Baxter, Stryker, Boston Scientific, Teleflex Medical, Medtronic, J +J, and Braun all have multiple Irish sites. There is also a strong global business services mandate, with 25% of our companies are engaged in such services,” she adds.
The Government’s policy and investments in STEM and support for innovation are also credited for the ongoing growth, coupled with client companies investments in the talent they are securing in Ireland, for the sector’s evolution from manufacture of class I non-invasive devices to today’s highly innovative Class II invasive devices and class III combination drug devices.
Martin Shanahan, IDA Ireland CEO, said that the very substantial contribution being made by the Life Sciences sector to Ireland’s economy is growing year on year.
“These are global companies operating at the highest level, using cutting edge technology and innovative processes to develop next generation medicines and medical devices to treat illnesses and medical conditions worldwide.”
He cites the example that the 25% of the world’s population that have diabetes rely on injectable devices manufactured in Ireland – that is over 30 million people. In addition, 50% of ventilators worldwide in acute hospitals are Irish made, 33% of the world’s contact lenses are manufactured here, 80% of global stent production is carried out in Ireland, as is 75% of global orthopaedic knee production.
“As a small island nation and against a backdrop of intense competition from other locations, geopolitical uncertainty and other challenges, we have developed a reputation in the sector that we can be justifiably proud of.”
There’s no better place in the world today for Life Science start-ups
The medical device eco-system in Ireland, in terms of access to specialised staff, managers, suppliers, advisers and investors is world-class. It is by far the best such system in an English speaking area within the favourable European regulatory regime.
The total Life Science sector, across medical devices, pharma and bio in Ireland:
Exports more than €45 billion annually.
Employs over 50,000 people directly.
Includes operations of six of the top seven diagnostics companies.
The Irish Medical Device sector:
Comprises 160 firms.
Employs more than 24,000 people.
Generates annual sales greater than €6 billion.
Includes operations of eight of the world’s 10 largest medical device companies.
Global players with substantial Irish operations include Abbott, Bayer, Becton Dickinson, Boston Scientific, Johnson & Johnson, Guidant, Medtronic and Stryker.
Ireland’s biggest home grown medical device company, Creganna/Tactx, employs over 800 people world-wide and provides a range of contract manufacturing and contract R&D services to start ups and global companies alike.
More than 50% of medtech companies based in Ireland have dedicated R&D facilities.
80% of global stent production is carried out from Ireland.
“Ireland is recognised as a centre for life sciences and medical devices. Enterprise Ireland was particularly helpful in facilitating introductions to Irish clinicians who have played a critical role in the product development process.” Chris Davey, Marvao Medical
Privacy & Cookies Policy
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.